A clinical cross-sectional study has shown that genetic variations in FNDC5 are associated with reduced brain glucose metabolism in patients with cognitive impairment, suggesting that FNDC5 may participate in brain metabolic regulation in regions susceptible to AD pathology (Ref. Here, FNDC5 is linked to Alzheimer disease.